Statistical inference and effect measures in abstracts of major HIV and AIDS journals, 1987-2022: A systematic review

1987-2022年主要HIV和AIDS期刊摘要中的统计推断和效应指标:系统评价

阅读:1

Abstract

OBJECTIVES: With the emergence of HIV/AIDS journals, the development of the reporting of statistical inference and effect measures in published abstracts can be examined from the beginning in a new field. The aim of this study was to describe time trends of statistical inference and effect measure reporting of major HIV/AIDS journals. METHODS: We included 10 major HIV/AIDS journals and analyzed all available PubMed entries for the period 1987 through 2022. We applied rule-based text mining and machine learning methodology to detect the presence of confidence intervals, numerical p-values or comparisons of p-values with thresholds, language describing statistical significance, and effect measures for dichotomous outcomes. RESULTS: Among 41,730 PubMed entries from the major HIV/AIDS journals, 31,665 contained an abstract. In the early years, most abstracts reporting statistical inference contained only significance terminology without confidence intervals and p-values. From 1988 to 2005, each year 30 % of all abstracts contained p-values without confidence intervals. Thereafter, this reporting style continued to decline. The reporting of confidence intervals increased steadily from 1988 (11 %) to 2022 (56 %). Of the 17 % of abstracts in 2017-2022 that included any effect measure, half reported odds ratios (51 %), followed by hazard ratios (28 %) and risk ratios (16 %). Difference measures and number needed to treat or harm were very uncommon. CONCLUSIONS: Within the HIV/AIDS literature, there has been widespread use of confidence intervals. Most of the journals that we reviewed had a decrease in reporting only statistical significance without confidence intervals over time.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。